105 related articles for article (PubMed ID: 2288053)
1. Nuclear DNA analysis: the relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years.
al-Abadi H; Nagel R
Urol Int; 1990; 45(6):350-5. PubMed ID: 2288053
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma.
Nagel R; al Abadi H
Scand J Urol Nephrol Suppl; 1991; 138():83-92. PubMed ID: 1785025
[TBL] [Abstract][Full Text] [Related]
3. Nuclear DNA analysis: DNA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma.
al-Abadi H; Nagel R
Eur Urol; 1992; 22(4):303-10. PubMed ID: 1490508
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
5. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
Borgmann V; al-Abadi H; Nagel R
Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
[TBL] [Abstract][Full Text] [Related]
7. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Borgmann V; al-Abadi H; Nagel R
Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
[TBL] [Abstract][Full Text] [Related]
8. Ploidy level and tumor progression in prostatic carcinoma.
Zetterberg A; Forsslund G
Acta Oncol; 1991; 30(2):193-9. PubMed ID: 2029404
[TBL] [Abstract][Full Text] [Related]
9. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
10. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
Forsslund G; Nilsson B; Zetterberg A
Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of nuclear DNA content in prostatic carcinoma.
Forsslund G; Esposti PL; Nilsson B; Zetterberg A
Cancer; 1992 Mar; 69(6):1432-9. PubMed ID: 1540880
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy in carcinoma of prostate.
Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of ploidy and proliferative activity of renal cell carcinoma.
Al-Abadi H; Nagel R
Eur Urol; 1988; 15(3-4):271-6. PubMed ID: 3215262
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer.
Adolfsson J; Rönström L; Hedlund PO; Löwhagen T; Carstensen J; Tribukait B
J Urol; 1990 Dec; 144(6):1404-6; discussion 1406-7. PubMed ID: 2231935
[TBL] [Abstract][Full Text] [Related]
15. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study.
Baretton GB; Vogt T; Blasenbreu S; Löhrs U
Hum Pathol; 1994 May; 25(5):506-13. PubMed ID: 8200645
[TBL] [Abstract][Full Text] [Related]
16. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison.
Humphrey PA; Walther PJ; Currin SM; Vollmer RT
Am J Surg Pathol; 1991 Dec; 15(12):1165-70. PubMed ID: 1746683
[TBL] [Abstract][Full Text] [Related]
17. DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma.
Müller JG; Demel S; Wirth MP; Manseck A; Frohmüller HG; Müller HA
Virchows Arch; 1994; 424(6):647-51. PubMed ID: 8055159
[TBL] [Abstract][Full Text] [Related]
18. Transrectal fine needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies.
Paz-Bouza JI; Orfao A; Abad M; Ciudad J; Garcia MC; Lopez A; Bullon A
Pathol Res Pract; 1994 Aug; 190(7):682-9. PubMed ID: 7528913
[TBL] [Abstract][Full Text] [Related]
19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
20. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
